Recruiting Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor NCT04616560 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States Children's Hospital Los Angeles — Los Angeles, California, United States Children's Hospital of Orange County — Orange, California, United States Lucile Packard Children's Hospital Stanford University — Palo Alto, California, United States View all 28 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors NCT02867592 Conditions Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States Providence Alaska Medical Center — Anchorage, Alaska, United States Arkansas Children's Hospital — Little Rock, Arkansas, United States Kaiser Permanente-Anaheim — Anaheim, California, United States View all 142 locations View more locations Show fewer locations Loading locations... View Trial Details
